In papillary thyroid cancer, METTL14 regulates miR‐98 expression by inhibiting OIP5‐AS1 expression and activates epidermal growth factor receptor (EGFR), MEK/ERK pathways to inhibit proliferation and migration/invasion of papillary thyroid cancer cells.42 Here, MAP2K7 is linked to thyroid gland papillary carcinoma.